Add-on maintenance treatment in adults from 18 yr w/ severe eosinophilic asthma who have at least 2 exacerbations in the past 12 mth on current standard therapy (high-dose inhaled corticosteroids + long-acting bronchodilators) &/or need for systemic corticosteroid treatment, or eosinophil blood count ≥300 cells/microliter.
Discontinue use if hypersensitivity reactions occur. Not to be administered in tender, bruised, erythematous or hardened skin. Not to be used for acute asthma exacerbations. Parasitic (helminth) infection. Avoid abrupt discontinuation of corticosteroids. Avoid use during pregnancy. Lactation. Childn 6-18 yr.
Sign Out
 30 mg_mLe5cbf3b3-8c3d-4d3f-9f68-ad5f00e3ba59.GIF)
